|
 |
 |
 |
 |
 |
 |
Projects Stroke: investigation of novel compounds in ischaemic stroke End Stage Renal Disease: treatment of hyperphosphataemia Chronic Kidney Disease (CKD): delay in progression of CKD Prevention of venous thromboembolic events Cardiovascular: cardiac protection following acute myocardial infarction in hospitalised patients Diabetes: novel control of diabetes For further details of Mitsubishi Tanabe Pharma Corporation development pipeline click here |
|||||
| © 2005 Mitsubishi Pharma Europe Terms of Use |
|||||
